|
| |
Oxytocin and Oxytocin Receptor
(OTR) and MafF Antibodies
The hypothalamic
Oxytocin (OT) is a nine-amino
acid peptide, which exerts multiple biological actions as a hormone and as
neurotransmitter. OT stimulates uterine smooth muscle and mammary myoepithelial
cell contraction, prostaglandin production by uterine endometrial and amnion
cells, milk ejaculation from the mammary gland, and induction of specific mating
behavior and maternal behaviors. Just before the onset of labor, uterine
myometrium becomes extremely sensitive to oxytocin, for which it is a primary
target tissue, because of a dramatic increase in the number of oxytocin
receptors. OT initiates its physiological activity by interacting with the G
protein-coupled receptor (GPCR) known as oxytocin
receptor (OTR). The encoded receptor is a
388-amino-acid polypeptide with 7 transmembrane domains typical of G
protein-coupled receptors. Messenger RNAs for the receptor are of two sizes, 3.6
kilobases in breast, and 4.4 kilobases in ovary, uterine endometrium and
myometrium. The mRNA level in the myometrium is very high at term.
The US-2 element in the promoter of the human oxytocin receptor gene (OTR) binds
specifically nuclear proteins from human myometrium at parturition. Using the
US-2 element in a yeast 1-hybrid system to screen a human myometrium cDNA
library, a full-length cDNA encoding the homolog of chicken
musculoaponeurotic fibrosarcoma oncogene family (MafF)
was isolated. Human MAfF (hMAfF)
(mouse 156-aa, chicken 149-aa, human 164-aa; chromosome 22q12.2-q13.2) is ~18
kDa protein. Like other small MAF proteins (e.g., MAFG) it contains an extended
leucine zipper structure and lacks an N-terminal transactivating domain. MafF is
strongly expressed in term myometrium and from kidney, but not from nonpregnant
myometrium. MAFF may play a role in OTR gene upregulation.
|
Items |
Antigen
peptide
location |
Ab
Host |
Ab
Cross-
reactivity |
Antiserum
Cat #
(100 ul) |
Aff.
Pure IgG
Cat #
(100 ug) |
* Control Peptide
Cat#
(100 ug) |
Oxytocin (OT) |
Rat
Oxytocin |
Rb |
r, m, h |
OT15-S |
OT15-A |
OT15-P |
Oxytocin Receptor
OTR |
Rat
20 aa ~CT |
Rb |
r, m, h |
OTR11-S |
OTR11-A |
OTR11-P |
|
MAfF
|
H 15-aa ~NT |
Rb
|
h, m, Ch
|
MAFF11-S
|
MAFF11-A
|
MAFF11-P
|
|
Control Rabbit IgG
|
For use in ELISA, Western,
Immunohisto.
|
20009-1 (1 mg)
|
m=mouse; r=rat; h=human; b=bovine; d=dog; ~CT
or ~NT=near C or N-terminus.
EC=Extracellular;
CP=Cytoplasmic domain; Control peptides (unconjugated, free,
antigenic peptides), because of their small size, are not
recommended for Western. They should be used in ELISA/antibody
blocking studies.
* Expected antibody crossreactivity
information is mostly based upon high (>70%) sequence conservation
of antigenic/control peptides in various species. When antibody
crossreactivity has actually been experimentally confirmed in
various species, it will be mentioned in the appropriate data sheets.
"Neat Antisera or antisera" are the
unpurified antiserum and it is suitable for ELISA and Western.
"Affinity pure" IgG may be more
suitable for immunohistochemical (IHC) applications and to reduce
background in most immunological applications including ELISA and
Western.
"Control peptides" can not be used for
Western as they are very short peptides. They are intended for ELISA
or antibody blocking studies to establish antibody specificity.
Western blot +ve protein controls, where available, are semi-pure,
pure or recombinant proteins that are formulated in SDS-PAGE sample
buffer. They are recommended to be used for Western (load 10 ul/lane)
for visualization with antibodies.
All Products are for in vitro research use
only
|